-
1
-
-
0034680102
-
Molecular portraits of human breast tumours
-
Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, et al. Molecular portraits of human breast tumours. Nature. 2000; 406:747-752.
-
(2000)
Nature
, vol.406
, pp. 747-752
-
-
Perou, C.M.1
Sorlie, T.2
Eisen, M.B.3
van de Rijn, M.4
Jeffrey, S.S.5
Rees, C.A.6
Pollack, J.R.7
Ross, D.T.8
Johnsen, H.9
Akslen, L.A.10
Fluge, O.11
Pergamenschikov, A.12
Williams, C.13
Zhu, S.X.14
Lonning, P.E.15
Borresen-Dale, A.L.16
-
2
-
-
60849097255
-
Gene-expression signatures in breast cancer
-
Sotiriou C and Pusztai L. Gene-expression signatures in breast cancer. N Engl J Med. 2009; 360(8):790-800.
-
(2009)
N Engl J Med
, vol.360
, Issue.8
, pp. 790-800
-
-
Sotiriou, C.1
Pusztai, L.2
-
4
-
-
0346339584
-
Current status and future directions in breast cancer therapy
-
Hudis CA. Current status and future directions in breast cancer therapy. Clinical breast cancer. 2003; 4 Suppl 2:S70-75.
-
(2003)
Clinical breast cancer
, vol.4
, pp. S70-75
-
-
Hudis, C.A.1
-
5
-
-
34948878051
-
Vaccine immunotherapy in breast cancer treatment: promising, but still early
-
Curigliano G, Spitaleri G, Dettori M, Locatelli M, Scarano E and Goldhirsch A. Vaccine immunotherapy in breast cancer treatment: promising, but still early. Expert Rev Anticancer Ther. 2007; 7:1225-1241.
-
(2007)
Expert Rev Anticancer Ther
, vol.7
, pp. 1225-1241
-
-
Curigliano, G.1
Spitaleri, G.2
Dettori, M.3
Locatelli, M.4
Scarano, E.5
Goldhirsch, A.6
-
6
-
-
29944440750
-
Towards a therapeutic breast cancer vaccine: the next steps
-
Emens LA. Towards a therapeutic breast cancer vaccine: the next steps. Expert review of vaccines. 2005; 4:831-841.
-
(2005)
Expert review of vaccines
, vol.4
, pp. 831-841
-
-
Emens, L.A.1
-
7
-
-
33745903909
-
Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients
-
Solomayer EF, Becker S, Pergola-Becker G, Bachmann R, Kramer B, Vogel U, Neubauer H, Wallwiener D, Huober J and Fehm TN. Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients. Breast Cancer Res Treat. 2006; 98:179-184.
-
(2006)
Breast Cancer Res Treat
, vol.98
, pp. 179-184
-
-
Solomayer, E.F.1
Becker, S.2
Pergola-Becker, G.3
Bachmann, R.4
Kramer, B.5
Vogel, U.6
Neubauer, H.7
Wallwiener, D.8
Huober, J.9
Fehm, T.N.10
-
8
-
-
0036605567
-
Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines
-
Disis ML, Gooley TA, Rinn K, Davis D, Piepkorn M, Cheever MA, Knutson KL and Schiffman K. Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines. J Clin Oncol. 2002; 20:2624-2632.
-
(2002)
J Clin Oncol
, vol.20
, pp. 2624-2632
-
-
Disis, M.L.1
Gooley, T.A.2
Rinn, K.3
Davis, D.4
Piepkorn, M.5
Cheever, M.A.6
Knutson, K.L.7
Schiffman, K.8
-
9
-
-
0032503501
-
Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide
-
Reddish M, MacLean GD, Koganty RR, Kan-Mitchell J, Jones V, Mitchell MS and Longenecker BM. Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide. International journal of cancer. 1998; 76:817-823.
-
(1998)
International journal of cancer
, vol.76
, pp. 817-823
-
-
Reddish, M.1
MacLean, G.D.2
Koganty, R.R.3
Kan-Mitchell, J.4
Jones, V.5
Mitchell, M.S.6
Longenecker, B.M.7
-
10
-
-
84879661529
-
CD4(+) follicular helper T cell infiltration predicts breast cancer survival
-
Gu-Trantien C, Loi S, Garaud S, Equeter C, Libin M, de Wind A, Ravoet M, Le Buanec H, Sibille C, Manfouo-Foutsop G, Veys I, Haibe-Kains B, Singhal SK, Michiels S, Rothe F, Salgado R, et al. CD4(+) follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest. 2013; 123:2873-2892.
-
(2013)
J Clin Invest
, vol.123
, pp. 2873-2892
-
-
Gu-Trantien, C.1
Loi, S.2
Garaud, S.3
Equeter, C.4
Libin, M.5
de Wind, A.6
Ravoet, M.7
Le Buanec, H.8
Sibille, C.9
Manfouo-Foutsop, G.10
Veys, I.11
Haibe-Kains, B.12
Singhal, S.K.13
Michiels, S.14
Rothe, F.15
Salgado, R.16
-
12
-
-
4143141823
-
The immunobiology of cancer immunosurveillance and immunoediting
-
Dunn GP, Old LJ and Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004; 21:137-148.
-
(2004)
Immunity
, vol.21
, pp. 137-148
-
-
Dunn, G.P.1
Old, L.J.2
Schreiber, R.D.3
-
13
-
-
79953151458
-
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion
-
Schreiber RD, Old LJ and Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science. 2011; 331:1565-1570.
-
(2011)
Science
, vol.331
, pp. 1565-1570
-
-
Schreiber, R.D.1
Old, L.J.2
Smyth, M.J.3
-
14
-
-
33847650413
-
Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?
-
Bui JD and Schreiber RD. Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes? Curr Opin Immunol. 2007; 19:203-208.
-
(2007)
Curr Opin Immunol
, vol.19
, pp. 203-208
-
-
Bui, J.D.1
Schreiber, R.D.2
-
15
-
-
0037456367
-
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
-
Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG and Schoenberger SP. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature. 2003; 421:852-856.
-
(2003)
Nature
, vol.421
, pp. 852-856
-
-
Janssen, E.M.1
Lemmens, E.E.2
Wolfe, T.3
Christen, U.4
von Herrath, M.G.5
Schoenberger, S.P.6
-
16
-
-
0031782910
-
The role of CD4+ T cell responses in antitumor immunity
-
Pardoll DM and Topalian SL. The role of CD4+ T cell responses in antitumor immunity. Curr Opin Immunol. 1998; 10:588-594.
-
(1998)
Curr Opin Immunol
, vol.10
, pp. 588-594
-
-
Pardoll, D.M.1
Topalian, S.L.2
-
17
-
-
1642497640
-
Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy
-
Wang HY, Lee DA, Peng G, Guo Z, Li Y, Kiniwa Y, Shevach EM and Wang RF. Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity. 2004; 20:107-118.
-
(2004)
Immunity
, vol.20
, pp. 107-118
-
-
Wang, H.Y.1
Lee, D.A.2
Peng, G.3
Guo, Z.4
Li, Y.5
Kiniwa, Y.6
Shevach, E.M.7
Wang, R.F.8
-
18
-
-
55749098500
-
Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer
-
Miyahara Y, Odunsi K, Chen W, Peng G, Matsuzaki J and Wang RF. Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc Natl Acad Sci U S A. 2008; 105:15505-15510.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 15505-15510
-
-
Miyahara, Y.1
Odunsi, K.2
Chen, W.3
Peng, G.4
Matsuzaki, J.5
Wang, R.F.6
-
19
-
-
84871317687
-
The role and regulation of human Th17 cells in tumor immunity
-
Ye J, Livergood RS and Peng G. The role and regulation of human Th17 cells in tumor immunity. Am J Pathol. 2013; 182(1):10-20.
-
(2013)
Am J Pathol
, vol.182
, Issue.1
, pp. 10-20
-
-
Ye, J.1
Livergood, R.S.2
Peng, G.3
-
20
-
-
79955758706
-
Th17 cells in cancer: help or hindrance?
-
Wilke CM, Kryczek I, Wei S, Zhao E, Wu K, Wang G and Zou W. Th17 cells in cancer: help or hindrance? Carcinogenesis. 2011; 32:643-649.
-
(2011)
Carcinogenesis
, vol.32
, pp. 643-649
-
-
Wilke, C.M.1
Kryczek, I.2
Wei, S.3
Zhao, E.4
Wu, K.5
Wang, G.6
Zou, W.7
-
21
-
-
44749092510
-
Regulatory T cells and treatment of cancer
-
Curiel TJ. Regulatory T cells and treatment of cancer. Curr Opin Immunol. 2008; 20:241-246.
-
(2008)
Curr Opin Immunol
, vol.20
, pp. 241-246
-
-
Curiel, T.J.1
-
22
-
-
16444378335
-
Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity
-
Emens LA, Reilly RT and Jaffee EM. Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity. Endocrine-related cancer. 2005; 12:1-17.
-
(2005)
Endocrine-related cancer
, vol.12
, pp. 1-17
-
-
Emens, L.A.1
Reilly, R.T.2
Jaffee, E.M.3
-
23
-
-
0036721629
-
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
-
Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, Drebin JA, Strasberg SM, Eberlein TJ, Goedegebuure PS and Linehan DC. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol. 2002; 169:2756-2761.
-
(2002)
J Immunol
, vol.169
, pp. 2756-2761
-
-
Liyanage, U.K.1
Moore, T.T.2
Joo, H.G.3
Tanaka, Y.4
Herrmann, V.5
Doherty, G.6
Drebin, J.A.7
Strasberg, S.M.8
Eberlein, T.J.9
Goedegebuure, P.S.10
Linehan, D.C.11
-
24
-
-
34249074242
-
CD4+CD25+ regulatory T-cell frequency in HER-2/neu (HER)-positive and HER-negative advanced-stage breast cancer patients
-
Perez SA, Karamouzis MV, Skarlos DV, Ardavanis A, Sotiriadou NN, Iliopoulou EG, Salagianni ML, Orphanos G, Baxevanis CN, Rigatos G and Papamichail M. CD4+CD25+ regulatory T-cell frequency in HER-2/neu (HER)-positive and HER-negative advanced-stage breast cancer patients. Clin Cancer Res. 2007; 13:2714-2721.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 2714-2721
-
-
Perez, S.A.1
Karamouzis, M.V.2
Skarlos, D.V.3
Ardavanis, A.4
Sotiriadou, N.N.5
Iliopoulou, E.G.6
Salagianni, M.L.7
Orphanos, G.8
Baxevanis, C.N.9
Rigatos, G.10
Papamichail, M.11
-
25
-
-
34548024379
-
Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway
-
Peng G, Wang HY, Peng W, Kiniwa Y, Seo KH and Wang RF. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity. 2007; 27:334-348.
-
(2007)
Immunity
, vol.27
, pp. 334-348
-
-
Peng, G.1
Wang, H.Y.2
Peng, W.3
Kiniwa, Y.4
Seo, K.H.5
Wang, R.F.6
-
26
-
-
30444443011
-
Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients
-
Haanen JB, Baars A, Gomez R, Weder P, Smits M, de Gruijl TD, von Blomberg BM, Bloemena E, Scheper RJ, van Ham SM, Pinedo HM and van den Eertwegh AJ. Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients. Cancer Immunol Immunother. 2006; 55:451-458.
-
(2006)
Cancer Immunol Immunother
, vol.55
, pp. 451-458
-
-
Haanen, J.B.1
Baars, A.2
Gomez, R.3
Weder, P.4
Smits, M.5
de Gruijl, T.D.6
von Blomberg, B.M.7
Bloemena, E.8
Scheper, R.J.9
van Ham, S.M.10
Pinedo, H.M.11
van den Eertwegh, A.J.12
-
27
-
-
33749319703
-
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
-
Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoue F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH and Pages F. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006; 313:1960-1964.
-
(2006)
Science
, vol.313
, pp. 1960-1964
-
-
Galon, J.1
Costes, A.2
Sanchez-Cabo, F.3
Kirilovsky, A.4
Mlecnik, B.5
Lagorce-Pages, C.6
Tosolini, M.7
Camus, M.8
Berger, A.9
Wind, P.10
Zinzindohoue, F.11
Bruneval, P.12
Cugnenc, P.H.13
Trajanoski, Z.14
Fridman, W.H.15
Pages, F.16
-
29
-
-
34247261531
-
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
-
Bates GJ, Fox SB, Han C, Leek RD, Garcia JF, Harris AL and Banham AH. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol. 2006; 24:5373-5380.
-
(2006)
J Clin Oncol
, vol.24
, pp. 5373-5380
-
-
Bates, G.J.1
Fox, S.B.2
Han, C.3
Leek, R.D.4
Garcia, J.F.5
Harris, A.L.6
Banham, A.H.7
-
30
-
-
64649088372
-
FOXP3 expression and overall survival in breast cancer
-
Merlo A, Casalini P, Carcangiu ML, Malventano C, Triulzi T, Menard S, Tagliabue E and Balsari A. FOXP3 expression and overall survival in breast cancer. J Clin Oncol. 2009; 27:1746-1752.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1746-1752
-
-
Merlo, A.1
Casalini, P.2
Carcangiu, M.L.3
Malventano, C.4
Triulzi, T.5
Menard, S.6
Tagliabue, E.7
Balsari, A.8
-
31
-
-
79954815112
-
An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer
-
Mahmoud SM, Paish EC, Powe DG, Macmillan RD, Lee AH, Ellis IO and Green AR. An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer. Breast Cancer Res Treat. 2011; 127:99-108.
-
(2011)
Breast Cancer Res Treat
, vol.127
, pp. 99-108
-
-
Mahmoud, S.M.1
Paish, E.C.2
Powe, D.G.3
Macmillan, R.D.4
Lee, A.H.5
Ellis, I.O.6
Green, A.R.7
-
32
-
-
79956329617
-
Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer
-
Mahmoud SM, Paish EC, Powe DG, Macmillan RD, Grainge MJ, Lee AH, Ellis IO and Green AR. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J Clin Oncol. 2011; 29:1949-1955.
-
(2011)
J Clin Oncol
, vol.29
, pp. 1949-1955
-
-
Mahmoud, S.M.1
Paish, E.C.2
Powe, D.G.3
Macmillan, R.D.4
Grainge, M.J.5
Lee, A.H.6
Ellis, I.O.7
Green, A.R.8
-
33
-
-
51349151553
-
Imagable 4T1 model for the study of late stage breast cancer
-
Tao K, Fang M, Alroy J and Sahagian GG. Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer. 2008; 8:228.
-
(2008)
BMC Cancer
, vol.8
, pp. 228
-
-
Tao, K.1
Fang, M.2
Alroy, J.3
Sahagian, G.G.4
-
34
-
-
27944470914
-
Distant metastasis from subcutaneously grown E0771 medullary breast adenocarcinoma
-
Ewens A, Mihich E and Ehrke MJ. Distant metastasis from subcutaneously grown E0771 medullary breast adenocarcinoma. Anticancer research. 2005; 25:3905-3915.
-
(2005)
Anticancer research
, vol.25
, pp. 3905-3915
-
-
Ewens, A.1
Mihich, E.2
Ehrke, M.J.3
-
35
-
-
77949329050
-
Tumor microenvironments direct the recruitment and expansion of human Th17 cells
-
Su X, Ye J, Hsueh EC, Zhang Y, Hoft DF and Peng G. Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J Immunol. 2010; 184:1630-1641.
-
(2010)
J Immunol
, vol.184
, pp. 1630-1641
-
-
Su, X.1
Ye, J.2
Hsueh, E.C.3
Zhang, Y.4
Hoft, D.F.5
Peng, G.6
-
36
-
-
79953045621
-
Human tumor-infiltrating Th17 cells have the capacity to differentiate into IFN-gamma+ and FOXP3+ T cells with potent suppressive function
-
Ye J, Su X, Hsueh EC, Zhang Y, Koenig JM, Hoft DF and Peng G. Human tumor-infiltrating Th17 cells have the capacity to differentiate into IFN-gamma+ and FOXP3+ T cells with potent suppressive function. Eur J Immunol. 2011; 41:936-951.
-
(2011)
Eur J Immunol
, vol.41
, pp. 936-951
-
-
Ye, J.1
Su, X.2
Hsueh, E.C.3
Zhang, Y.4
Koenig, J.M.5
Hoft, D.F.6
Peng, G.7
-
37
-
-
84868578365
-
Tumor-infiltrating gammadelta T lymphocytes predict clinical outcome in human breast cancer
-
Ma C, Zhang Q, Ye J, Wang F, Zhang Y, Wevers E, Schwartz T, Hunborg P, Varvares MA, Hoft DF, Hsueh EC and Peng G. Tumor-infiltrating gammadelta T lymphocytes predict clinical outcome in human breast cancer. J Immunol. 2012; 189:5029-5036.
-
(2012)
J Immunol
, vol.189
, pp. 5029-5036
-
-
Ma, C.1
Zhang, Q.2
Ye, J.3
Wang, F.4
Zhang, Y.5
Wevers, E.6
Schwartz, T.7
Hunborg, P.8
Varvares, M.A.9
Hoft, D.F.10
Hsueh, E.C.11
Peng, G.12
-
38
-
-
36349037090
-
Rejection of metastatic 4T1 breast cancer by attenuation of Treg cells in combination with immune stimulation
-
Chen L, Huang TG, Meseck M, Mandeli J, Fallon J and Woo SL. Rejection of metastatic 4T1 breast cancer by attenuation of Treg cells in combination with immune stimulation. Molecular therapy : the journal of the American Society of Gene Therapy. 2007; 15:2194-2202.
-
(2007)
Molecular therapy : the journal of the American Society of Gene Therapy
, vol.15
, pp. 2194-2202
-
-
Chen, L.1
Huang, T.G.2
Meseck, M.3
Mandeli, J.4
Fallon, J.5
Woo, S.L.6
-
39
-
-
29444442811
-
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
-
Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C, Kepner J, Odunsi T, Ritter G, Lele S, Chen YT, Ohtani H, et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A. 2005; 102:18538-18543.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 18538-18543
-
-
Sato, E.1
Olson, S.H.2
Ahn, J.3
Bundy, B.4
Nishikawa, H.5
Qian, F.6
Jungbluth, A.A.7
Frosina, D.8
Gnjatic, S.9
Ambrosone, C.10
Kepner, J.11
Odunsi, T.12
Ritter, G.13
Lele, S.14
Chen, Y.T.15
Ohtani, H.16
-
40
-
-
73349142719
-
In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer
-
Pages F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, Bindea G, Lagorce C, Wind P, Marliot F, Bruneval P, Zatloukal K, Trajanoski Z, Berger A, Fridman WH and Galon J. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol. 2009; 27:5944-5951.
-
(2009)
J Clin Oncol
, vol.27
, pp. 5944-5951
-
-
Pages, F.1
Kirilovsky, A.2
Mlecnik, B.3
Asslaber, M.4
Tosolini, M.5
Bindea, G.6
Lagorce, C.7
Wind, P.8
Marliot, F.9
Bruneval, P.10
Zatloukal, K.11
Trajanoski, Z.12
Berger, A.13
Fridman, W.H.14
Galon, J.15
-
41
-
-
84866171012
-
Human regulatory T cells induce T-lymphocyte senescence
-
Ye J, Huang X, Hsueh EC, Zhang Q, Ma C, Zhang Y, Varvares MA, Hoft DF and Peng G. Human regulatory T cells induce T-lymphocyte senescence. Blood. 2012; 120:2021-2031.
-
(2012)
Blood
, vol.120
, pp. 2021-2031
-
-
Ye, J.1
Huang, X.2
Hsueh, E.C.3
Zhang, Q.4
Ma, C.5
Zhang, Y.6
Varvares, M.A.7
Hoft, D.F.8
Peng, G.9
-
42
-
-
84886040918
-
Specific recruitment of gammadelta regulatory T cells in human breast cancer
-
Ye J, Ma C, Wang F, Hsueh EC, Toth K, Huang Y, Mo W, Liu S, Han B, Varvares MA, Hoft DF and Peng G. Specific recruitment of gammadelta regulatory T cells in human breast cancer. Cancer Res. 2013; 73:6137-6148.
-
(2013)
Cancer Res
, vol.73
, pp. 6137-6148
-
-
Ye, J.1
Ma, C.2
Wang, F.3
Hsueh, E.C.4
Toth, K.5
Huang, Y.6
Mo, W.7
Liu, S.8
Han, B.9
Varvares, M.A.10
Hoft, D.F.11
Peng, G.12
-
43
-
-
23944509107
-
Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function
-
Peng G, Guo Z, Kiniwa Y, Voo KS, Peng W, Fu T, Wang DY, Li Y, Wang HY and Wang RF. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science. 2005; 309:1380-1384.
-
(2005)
Science
, vol.309
, pp. 1380-1384
-
-
Peng, G.1
Guo, Z.2
Kiniwa, Y.3
Voo, K.S.4
Peng, W.5
Fu, T.6
Wang, D.Y.7
Li, Y.8
Wang, H.Y.9
Wang, R.F.10
-
44
-
-
84874263560
-
Tumor-Derived gammadelta Regulatory T Cells Suppress Innate and Adaptive Immunity through the Induction of Immunosenescence
-
Ye J, Ma C, Hsueh EC, Eickhoff CS, Zhang Y, Varvares MA, Hoft DF and Peng G. Tumor-Derived gammadelta Regulatory T Cells Suppress Innate and Adaptive Immunity through the Induction of Immunosenescence. J Immunol. 2013; 190:2403-2414.
-
(2013)
J Immunol
, vol.190
, pp. 2403-2414
-
-
Ye, J.1
Ma, C.2
Hsueh, E.C.3
Eickhoff, C.S.4
Zhang, Y.5
Varvares, M.A.6
Hoft, D.F.7
Peng, G.8
|